Publications

Export 106 results:
Auteur Title Type [ Année(Desc)]
Filtres: Auteur is Malla, Ashok  [Enlever les filtres]
2010
Lepage M, Bodnar M, Joober R, Malla A.  2010.  Is there an association between neurocognitive performance and medication adherence in first episode psychosis? Early Interv Psychiatry. 4(2):189-95.
2011
Buchy L, Ad-Dab'bagh Y, Malla A, Lepage C, Bodnar M, Joober R, Sergerie K, Evans A, Lepage M.  2011.  Cortical thickness is associated with poor insight in first-episode psychosis.. J Psychiatr Res. 45(6):781-7.
Luck D, Buchy L, Czechowska Y, Bodnar M, G Pike B, Campbell JSW, Achim A, Malla A, Joober R, Lepage M.  2011.  Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study.. J Psychiatr Res. 45(3):369-77.
2012
Buchy L, Luck D, Czechowska Y, Malla A, Joober R, Lepage M.  2012.  Diffusion tensor imaging tractography of the fornix and belief confidence in first-episode psychosis.. Schizophr Res. 137(1-3):80-4.
Buchy L, Ad-Dab'bagh Y, Lepage C, Malla A, Joober R, Evans A, Lepage M.  2012.  Symptom attribution in first episode psychosis: a cortical thickness study.. Psychiatry Res. 203(1):6-13.
2013
Lutgens D, Lepage M, Manchanda R, Malla A.  2013.  Persistent negative symptoms in schizophrenia: survey of Canadian psychiatrists.. Int Psychiatry. 10(3):69-72.
2014
Cassidy C, Buchy L, Bodnar M, Dell'elce J, Choudhry Z, Fathalli F, Sengupta S, Fox R, Malla A, Lepage M et al..  2014.  Association of a risk allele of ANK3 with cognitive performance and cortical thickness in patients with first-episode psychosis.. J Psychiatry Neurosci. 39(1):31-9.
Malla A, Jordan G, Joober R, Schmitz N, Norman R, Brown TG, Goldberg K, Loohuis H, Vracotas N, Rochford J.  2014.  A controlled evaluation of a targeted early case detection intervention for reducing delay in treatment of first episode psychosis.. Soc Psychiatry Psychiatr Epidemiol. 49(11):1711-8.
Cassidy CM, Lepage M, Malla A.  2014.  Do motivation deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of behavioural response to natural rewards and drug cues. Psychiatry Res. 215(3):522-7.
Cassidy CM, Brodeur MB, Lepage M, Malla A.  2014.  Do reward-processing deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of physiological response to natural rewards and drug cues. J Psychiatry Neurosci. 39(5):339-47.
Iyer SN, Malla A.  2014.  [Early intervention in psychosis: concepts, current knowledge and future directions].. Sante Ment Que. 39(2):201-29.
Manchanda R, Norman R, Malla A, Harricharan R, Northcott S, Richard J.  2014.  Electroencephalographic abnormalities and 5-year outcome in first-episode psychosis.. Can J Psychiatry. 59(5):285-8.
Schmitz N, Gariépy G, Smith KJ, Malla A, Boyer R, Strychar I, Lesage A, Wang JL.  2014.  Longitudinal relationships between depression and functioning in people with type 2 diabetes.. Ann Behav Med. 47(2):172-9.
Lal S, Ungar M, Malla A, Frankish J, Suto M.  2014.  Meanings of well-being from the perspectives of youth recently diagnosed with psychosis.. J Ment Health. 23(1):25-30.
Lutgens D, Lepage M, Iyer S, Malla A.  2014.  Predictors of cognition in first episode psychosis.. Schizophr Res. 152(1):164-9.
Schmitz N, Gariépy G, Smith KJ, Clyde M, Malla A, Boyer R, Strychar I, Lesage A, Wang JL.  2014.  Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes.. Diabetes Care. 37(4):970-8.
Tibbo P, Malla A, Manchanda R, Williams R, Joober R.  2014.  Relapse risk assessment in early phase psychosis: the search for a reliable and valid tool.. Can J Psychiatry. 59(12):655-8.
Jordan G, Lutgens D, Joober R, Lepage M, Iyer SN, Malla A.  2014.  The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis.. J Clin Psychiatry. 75(6):e566-72.
Schmitz N, Gariépy G, Smith KJ, Clyde M, Malla A, Boyer R, Strychar I, Lesage A, Wang JL.  2014.  Response to comment on Schmitz et al. Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes. Diabetes care 2014;37:970-978.. Diabetes Care. 37(6):e146-7.
Malla A.  2014.  The role of cognition in outcome in schizophrenia and related disorders.. Can J Psychiatry. 59(1):3-4.
Albanna A, Choudhry Z, Harvey P-O, Fathalli F, Cassidy C, Sengupta SM, Iyer SN, Rho A, Lepage M, Malla A et al..  2014.  TCF4 gene polymorphism and cognitive performance in patients with first episode psychosis.. Schizophr Res. 152(1):124-9.
Latimer E, Naidu A, Moodie EEM, Clark RE, Malla A, Tamblyn R, Wynant W.  2014.  Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.. Psychiatr Serv. 65(10):1210-7.
Messier L, Elisha B, Schmitz N, Gariépy G, Malla A, Lesage A, Boyer R, Wang JL, Strychar I.  2014.  Weight cycling and depressive symptoms in diabetes: a community-based study of adults with type 2 diabetes mellitus in Quebec.. Can J Diabetes. 38(6):456-60.
2015
Pruessner M, Faridi K, Shah JL, Rabinovitch M, Iyer SN, Abadi S, Pawliuk N, Joober R, Malla A.  2015.  The Clinic for Assessment of Youth at Risk (CAYR): 10 years of service delivery and research targeting the prevention of psychosis in Montreal, Canada.. Early Interv Psychiatry.
Rho A, Traicu A, Lepage M, Iyer SN, Malla A, Joober R.  2015.  Clinical and functional implications of a history of childhood ADHD in first-episode psychosis.. Schizophr Res. 165(2-3):128-33.

Pages